While Moderna has been focused on building out its manufacturing apparatus in North America, Europe and Africa, the company appears to be turning toward Japan for its next act.
According to a report from Nikkei Asia, Moderna CEO Stéphane Bancel said the company would like to build a facility in Japan as well as centralize all processes, including manufacturing, into a single facility.
While no other details on the manufacturing site were offered, such as location and timing, Bancel said the site would ideally manufacture vaccines for Covid-19, flu and other diseases. Endpoints News reached out to Moderna to get more details on the matter but they did not respond by press time.
Bancel said any construction in Japan would be based on “having a contract for a set period of time (for vaccine purchases).” Nikkei Asia noted that Bancel is seeking a 10-year agreement between…
Click here to view original post